Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-23

Clinical Trial Update: Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing generic adapalene and benzoyl peroxide gel to Epiduo Forte for acne vulgaris has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epiduo Forte Gel (adapalene and benzoyl peroxide)
  • Generic adapalene and benzoyl peroxide gel (adapalene + benzoyl peroxide)

Snippet

Sponsor: Actavis Inc. | Conditions: Acne | Phase 3 | Status: COMPLETED | Results posted: 2020-06-23